• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Flow Cytometry Market - Product Image

Global Flow Cytometry Market

  • Published: June 2012
  • Region: Global
  • 112 Pages
  • TriMark Publications

FEATURED COMPANIES

  • ALPCO Diagnostics
  • Cell Signaling Technology
  • DVS Sciences, Inc.
  • Nihon Kohden
  • Sigma-Aldrich
  • Takara Bio
  • MORE

Flow cytometry is a laboratory analytical technique that can rapidly measure multiple parameters of individual cells or particles as they pass through a beam of light, typically a laser. The global flow cytometry market remains one of the fastest-growing segments of life sciences and clinical diagnostics markets. In the current life sciences research, pharmaceutical drug discovery and development, and clinical diagnostics markets, flow cytometry offers some of the brightest promise for growth and innovation.

The purpose of this TriMark Publications report is to provide a detailed analysis of the global flow cytometry market, including size, growth, technology platforms, applications, new instrumentation, industry trends and the internal structure of the sector. The study covers highly attractive growth areas such as stem cell research, biomarkers and companion diagnostics, CD4 testing, high throughput screening and immunology and vaccine development.

It also analyzes almost all of the companies known to be marketing, manufacturing or developing flow cytometry products in the U.S. and worldwide. Additionally, this review provides detailed tables, charts and figures with past and projected sales data by geographic region for North America, Europe, Asia-Pacific and the emerging BRIC (Brazil, Russia, India and China) markets.

1. Overview
1.1 Statement of Report
1.2 About This Report
1.3 Objectives
1.4 Scope of the Report
1.5 Methodology
1.6 Executive Summary

2. Background and Development

3. Market Overview
3.1 Technology and Products
3.2 Market Environment
3.2.1 Global Economic Uncertainty
3.2.2 Lower Healthcare Utilization
3.2.3 Reduced Government Funding for Life Science Research
3.2.4 Consolidation of the Pharmaceutical Industry
3.2.5 Global Aid to Resource Limited Countries
3.3 Users
3.3.1 Overview
3.3.2 Research
3.3.3 Clinical
3.3.4 Pharmaceutical
3.3.5 Niche

4. Global Market Forecast
4.1 Overview
4.2 Market Drivers
4.3 Market Restrictors
4.4 Market by User

5. Product Forecast
5.1 Instrument Forecast
5.2 Reagents and Consumables Forecast
5.3 Software Forecast

6. The Global Market for CD4 T-Cell Testing

7. Market Analysis by Region
7.1 Overview
7.2 Developed Markets
7.2.1 North America
7.2.1.1 Research
7.2.1.2 Pharmaceutical
7.2.1.3 Clinical Diagnostics
7.2.2 Europe Flow Cytometry Market Analysis
7.2.2.1 Overview
7.2.2.2 Research
7.2.2.3 Pharmaceutical and Biotechnology
7.2.2.4 Clinical Diagnostics
7.2.3 Asia-Pacific
7.2.3.1 Overview
7.2.3.2 Research
7.2.3.3 Pharmaceutical and Biotechnology
7.2.3.4 Clinical Diagnostics
7.3 Emerging Markets
7.3.1 Overview
7.3.2 Brazil
7.3.2.1 Research
7.3.2.2 Clinical Diagnostics
7.3.2.3 Pharmaceutical
7.3.3 Russia
7.3.3.1 Overview
7.3.3.2 Research
7.3.3.3 Pharmaceutical and Biotechnology
7.3.3.4 Clinical Diagnostics
7.3.4 India
7.3.4.1 Overview
7.3.4.2 Research
7.3.4.3 Pharmaceutical and Biotechnology
7.3.4.4 Clinical Diagnostics
7.3.5 China
7.3.5.1 Overview
7.3.5.2 Research
7.3.5.3 Pharmaceutical and Biotechnology
7.3.5.4 Clinical Diagnostics
7.4 Resource Limited Countries

8. Technology
8.1 Principle of Flow Cytometry
8.2 Fluidics
8.3 Optics
8.4 Electronics
8.5 Data Analysis
8.6 Cell Sorting
8.7 Labeling and Detection
8.8 Multiplex Bead Assays
8.9 Imaging Flow Cytometry

9. Applications
9.1 Research Applications
9.1.1 Detection of Cell Signaling Pathways in Single Cells
9.1.2 Cell Proliferation
9.1.3 Cell Viability
9.1.4 Apoptosis
9.1.5 Cell Cycle, DNA Content, Gene Expression
9.1.6 Multiplex Bead Assays
9.1.7 Stem Cell Research
9.1.8 Immunology Research and Vaccine Development
9.2 Clinical Diagnostics
9.2.1 Monitoring T-Cell Markers
9.2.2 Immunophenotyping of Leukemias and Lymphomas
9.2.3 Detection of Minimum Residual Disease (MRD)
9.2.4 Anti-Neutrophil Antibody Detection in Auto-Immune and Immunodeficiency Disease
9.2.5 Platelet Associated Immunoglobulin Assays
9.2.6 Reticulocyte Count
9.2.7 HLA Crossmatching and Cell Analysis for Stem Cell and Organ Transplantation
9.2.8 Paroxysmal Nocturnal Hemoblobinuria
9.3 Pharmaceutical Applications
9.3.1 Biomarkers and Companion Diagnostics
9.3.2 Drug Discovery and High Throughput Screening
9.3.3 Toxicology
9.3.4 GMP Manufacture of Cellular Therapeutics

10. Global Health
10.1 Parasitic Diseases and Tropical Medicine
10.2 HIV/AIDS, Malaria and Tuberculosis

11. Niche Applications
11.1 Marine Biology
11.2 Plant Biology, Agriculture and Veterinary Medicine
11.3 Microbiology
11.3.1 Clinical Microbiology
11.3.2 Industrial Microbiology
11.4 Monitor Fermentation Processes
11.5 Monitor Water Quality
11.6 Screening Raw Materials and Finished Product

12. Flow Cytometry Products
12.1 Buying Decisions
12.2 Reagent Selection
12.3 Pricing
12.4 Instrument Key Features
12.4.1 High Performance Multicolor Analyzers
12.4.2 Cell Sorters
12.4.3 Compact Flow Cytometers for Individual Laboratories
12.4.4 Flow Cytometry Imaging Systems
12.4.5 High Throughput and Automated Systems
12.5 Multiplex Bead Systems
12.6 POC Instruments for CD4 Enumeration
12.7 Leading Suppliers of Reagents and Kits
12.8 Software and Bioinformatics

13. Competitive Analysis
13.1 Competitor Market Share
13.2 Competitive Landscape
13.2.1 Overview
13.2.2 Key Players
13.2.3 Products
13.3 Competitive Analysis of Key Players
13.3.1 BD Biosciences
13.3.2 Beckman Coulter
13.3.3 Life Technologies
13.3.4 Luminex Corporation
13.3.5 EMD Millipore
13.3.6 Partec
13.3.7 Miltenyi Biotec
13.3.8 Bioscience (a Division of Affymetrix)

14. Industry Analysis
14.1 Trends
14.1.1 More Lasers, More Fluorescent Dyes, More Data
14.1.2 Moving Flow Cytometry Out of Core Laboratories
14.1.3 Higher Throughput
14.1.4 Clinical Scale Cell Sorting
14.1.5 POC Flow Cytometry
14.2 Recent Industry Developments
14.3 Innovation and New Technology
14.3.1 Mass Cytometry
14.3.2 Micro-Fabricated Fluorescence-Activated Cell Sorter
14.3.3 Damage-Less Cell Sorting
14.3.4 Flow Cytometry and a Cell Phone
14.3.5 Disposable Devices for CD4 T-Cell Enumeration
14.4 Gaps and Challenges
14.4.1 Software
14.4.2 POC CD4 Testing
14.5 Opportunities
14.5.1 Integrating Complementary Technologies
14.5.2 Automated Compound Screening
14.5.3 Specialized Flow Cytometers
14.5.3.1 Veterinary Testing
14.5.3.2 Marine Biology Systems
14.5.3.3 Plant Biology
14.6 Strategic Recommendations
14.6.1 Competing in the Flow Cytometry Market
14.6.2 International Operations Risks
14.6.3 Dependence on Government Funding and Healthcare Reform
14.6.4 Reimbursement for Clinical Diagnostics

15. Company Profiles
15.1 AbD Serotec (part of MorphoSys)
15.2 ALPCO Diagnostics
15.3 Apogee Flow Systems
15.4 Bay Bioscience
15.5 BioCytex (Part of the Stago Group)
15.6 BioVision
15.7 Blue Ocean Medical
15.8 Cell Signaling Technology
15.9 Cira Discovery Sciences
15.10 Clarient
15.11 Cytobank, Inc.
15.12 CytonomeST
15.13 DVS Sciences, Inc.
15.14 iCyt Mission Technology
15.15 IntelliCyt Corporation
15.16 Miltenyi Biotec
15.17 Mindray
15.18 MiraiBio Group (Part of Hitachi Solutions America)
15.19 Nihon Kohden
15.20 Partec
15.21 PointCare Technologies
15.22 Promega Corporation
15.23 Santa Cruz Biotechnology
15.24 Sigma-Aldrich
15.25 Soft Flow
15.26 SouthernBiotech
15.27 Stratedigm
15.28 Sysmex
15.29 Takara Bio
15.30 Techne Corporation
15.31 Tree Star
15.32 TTP LabTech
15.33 Union Biometrica
15.34 U.S. Biological
15.35 Verity Software House

16. Acronyms Used in This Report

INDEX OF FIGURES

Figure 4.1: Market Share by Segment
Figure 5.1: Product Revenue Forecast, 2011-2017
Figure 5.2: Product Revenue Growth
Figure 5.3: Product Revenue Distribution
Figure 7.1: Global Flow Cytometry Market by Region
Figure 7.2: Five-Year Forecast by Region, 2011-2017
Figure 7.3: Annual Growth by Region
Figure 7.4: European Market Share by Country
Figure 7.5: Flow Cytometry Emerging Markets Forecast, 2011-2017
Figure 7.6: Emerging Market Share by Country, 2011
Figure 7.7: Growth Rate?Emerging Countries
Figure 8.1: Schematic of a Flow Cell
Figure 8.2: Schematic of a Flow Cytometer Optical Layout
Figure 8.3: Example of a Dot Plot of Lysed Whole Blood
Figure 8.4: Principle of Multiplex Bead Assay
Figure 13.1: Flow Cytometry Competitor?s Market Share

INDEX OF TABLES

Table 2.1: Flow Cytometry Timeline
Table 3.1: Differences between Hematology Analyzers and Flow Cytometers
Table 3.2: Flow Cytometry Market Environment
Table 4.1: Global Revenue Forecast, 2011-2017
Table 5.1: Product Revenue Forecast, 2011-2017
Table 6.1: Number of Adults and Children Living with HIV in 2010, Lower to Middle Income Countries
Table 6.2: Regional Antiretroviral Therapy Coverage
Table 7.1: Global Flow Cytometry Market Forecast by Region, 2011-2017
Table 7.2: NIH Funding for Stem Cell Research, 2011-2013
Table 7.3: North America Revenue Forecast, 2011-2017
Table 7.4: NIH Historical Spending, 2008-2012
Table 7.5: Flow Cytometry Systems in NIH Core Flow Cytometry Facilities
Table 7.6: CROs Specializing in Flow Cytometry Services
Table 7.7: European Product Forecast, 2011-2017
Table 7.8: European Revenue Forecast by Country, 2011-2017
Table 7.9: Asia-Pacific Revenue Forecast, 2011-2017
Table 7.10: Emerging Markets Product Revenue Forecast, 2011-2017
Table 7.11: Emerging Markets Revenue Forecast by Country, 2011-2017
Table 7.12: Resource Limited Markets. Product Revenue Forecast, 2011-2017
Table 8.1: Common Fluorophores Used in Flow Cytometry
Table 9.1: Cell Types, Proteins and Microbes Detected by Flow Cytometry
Table 9.2: Flow Cytometry Applications in Stem Cell Research
Table 9.3: Flow Cytometry Clinical Diagnostic Applications
Table 9.4: NIH Definition of Biomarkers
Table 9.5: Advantages of Flow Cytometry for High Throughput Screening
Table 9.6: Flow Cytometry Applications for Toxicology
Table 10.1: Neglected Tropical Diseases
Table 11.1: Flow Cytometers Products for Niche Applications
Table 11.2: Microorganisms Detected by Flow Cytometry
Table 12.1: Considerations When Selecting a Flow Cytometer
Table 12.2: Features: High Performance Analyzers
Table 12.3: Features: Cell Sorters
Table 12.4: Features: Compact Analyzers for Individual Laboratories
Table 12.5: Features: Midsize Analyzers for Clinical IVD Applications
Table 12.6: Features: MidSize Analyzers for Research Applications
Table 12.7: Multiplex Bead Systems. Key Features
Table 12.8: Suppliers of Flow Cytometry Instruments, Reagents and Software
Table 13.1: North American Companies Participating in the Flow Cytometry Market
Table 13.2: European Companies Participating in the Flow Cytometry Market
Table 13.3: Asian Companies Participating in the Flow Cytometry Market
Table 13.4: BD Biosciences Selection of Flow Cytometry Instruments
Table 13.5: Beckman Coulter Flow Cytometry Instruments
Table 13.6: Life Technologies Flow Cytometry Instruments
Table 13.7: Luminex Products
Table 13.8: Millipore Flow Cytometry Instruments
Table 13.9: Partec Flow Cytometry Instruments

- AbD Serotec (part of MorphoSys)
- ALPCO Diagnostics
- Apogee Flow Systems
- Bay Bioscience
- BioCytex (Part of the Stago Group)
- BioVision
- Blue Ocean Medical
- Cell Signaling Technology
- Cira Discovery Sciences
- Clarient
- Cytobank, Inc.
- CytonomeST
- DVS Sciences, Inc.
- iCyt Mission Technology
- IntelliCyt Corporation
- Miltenyi Biotec
- Mindray
- MiraiBio Group (Part of Hitachi Solutions America)
- Nihon Kohden
- Partec
- PointCare Technologies
- Promega Corporation
- Santa Cruz Biotechnology
- Sigma-Aldrich
- Soft Flow
- SouthernBiotech
- Stratedigm
- Sysmex
- Takara Bio
- Techne Corporation
- Tree Star
- TTP LabTech
- Union Biometrica
- U.S. Biological
- Verity Software House

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos